Jubilant Ingrevia Ltd Hits Intraday High with 8.05% Surge on 3 Feb 2026

Intraday Trading Highlights

The stock opened with a significant gap up of 16.87%, signalling strong buying interest from the outset. Throughout the trading day, Jubilant Ingrevia demonstrated high volatility, with an intraday volatility of 6.86% calculated from the weighted average price. This volatility underscored active trading and price fluctuations within the session.

Despite the strong opening, the stock’s price movement remained contained within the day’s high of Rs 718.55, which represents the peak level reached during the session. The closing price reflected an 8.05% increase from the previous day’s close, outperforming the Pharmaceuticals & Drugs sector, which gained 2.92% on the same day.

Jubilant Ingrevia’s performance also outshone the Sensex, which, after an initial gap up of 3,656.74 points, lost momentum and closed down by 2.62% at 83,803.45 points. The stock’s 1-day gain of 8.36% notably exceeded the Sensex’s 2.60% rise, highlighting its relative strength in a mixed market environment.

Technical Positioning and Market Context

From a technical perspective, Jubilant Ingrevia’s price currently trades above its 5-day moving average, indicating short-term positive momentum. However, it remains below its 20-day, 50-day, 100-day, and 200-day moving averages, suggesting that the stock is still navigating longer-term resistance levels.

The stock reversed its trend after two consecutive days of decline, signalling a potential shift in intraday sentiment. This reversal contributed to the strong intraday gains observed on 3 Feb 2026.

Within the broader market, the Sensex is trading 2.81% below its 52-week high of 86,159.02. The index’s 50-day moving average remains above its 200-day moving average, a technical indicator often interpreted as a positive medium-term trend. Mega-cap stocks led the market gains, although Jubilant Ingrevia, a specialty chemicals small-cap, outperformed both the sector and the benchmark index.

Performance Relative to Benchmarks

Jubilant Ingrevia’s recent performance shows a mixed trend over various time frames. While the stock outperformed the Sensex over the past day and week, with gains of 8.36% and 7.48% respectively compared to the Sensex’s 2.60% and 2.36%, it lagged behind over longer periods. The stock recorded a 1-month decline of 8.33% versus the Sensex’s 2.30% drop, and a 3-month loss of 3.71% compared to the Sensex’s 0.23% fall.

Over the year, Jubilant Ingrevia’s performance was negative at -7.72%, contrasting with the Sensex’s positive 8.55% gain. Year-to-date figures also show the stock down by 5.36%, while the Sensex declined by 1.68%. However, the stock has delivered a 39.50% return over three years, slightly outperforming the Sensex’s 37.71% gain during the same period.

Longer-term returns over five and ten years are flat for Jubilant Ingrevia, whereas the Sensex has recorded substantial gains of 66.72% and 245.90% respectively, reflecting the stock’s relative underperformance in the extended timeframe.

Mojo Score and Ratings Update

Jubilant Ingrevia currently holds a Mojo Score of 43.0, categorised as a Sell grade. This represents a downgrade from its previous Hold rating, effective from 12 Jan 2026. The company’s market capitalisation grade stands at 3, indicating a mid-tier market cap within its sector.

The downgrade reflects recent assessments of the company’s financial and market metrics, despite the strong intraday price action observed on 3 Feb 2026. The Mojo grading system provides a comprehensive evaluation of stock quality, trend, and valuation, which investors may consider alongside price movements.

Sector and Market Dynamics

The specialty chemicals sector, to which Jubilant Ingrevia belongs, has shown resilience with a 2.92% gain on the day. This sectoral performance was stronger than the broader market’s mixed results, where the Sensex experienced a sharp intraday reversal after a strong opening.

Jubilant Ingrevia’s outperformance relative to its sector and the Sensex highlights its distinct trading behaviour on 3 Feb 2026. The stock’s ability to open with a gap up and sustain gains above short-term moving averages suggests active participation by market participants during the session.

However, the stock remains below key longer-term moving averages, indicating that it is still navigating resistance levels that may influence future price action.

Summary of Key Metrics

On 3 Feb 2026, Jubilant Ingrevia Ltd’s stock price:

• Opened with a 16.87% gap up
• Reached an intraday high of Rs 718.55
• Closed with an 8.05% gain on the day
• Exhibited intraday volatility of 6.86%
• Outperformed the Pharmaceuticals & Drugs sector by 5.62%
• Outperformed the Sensex by 5.76% on a 1-day basis

These figures illustrate a day of strong price action and active trading for Jubilant Ingrevia, contrasting with the broader market’s more subdued performance.

Conclusion

Jubilant Ingrevia Ltd’s strong intraday surge on 3 Feb 2026, marked by a significant gap up and an 8.05% gain, reflects notable market activity and relative strength within the specialty chemicals sector. While the stock’s technical positioning shows mixed signals with short-term momentum but longer-term resistance, the day’s trading highlights its capacity for volatility and price movement in a fluctuating market environment.

Investors and market watchers will note the stock’s performance in the context of its recent downgrade to a Sell grade and its comparative returns against the Sensex and sector benchmarks.

Upgrade at special rates, valid only for the next few days. Claim Your Special Rate →